A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers
iOnctura
iOnctura
Endeavor Biomedicines, Inc.
Kezar Life Sciences, Inc.
SOLTI Breast Cancer Research Group
Memorial Sloan Kettering Cancer Center
University of Florida
Incyte Corporation
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)